DrugCombo is a comprehensive knowledge base that integrates drug toxicity and pharmacokinetic data for single drugs and drug combinations from the United States Food and Drug Administration Adverse Event Report System (FAERS), drug labeling from the National Library of Medicine’s DailyMed website, published study results in PubMed, and the DrugBank database. DrugCombo is the first database to contain crucial data, such as the maximum tolerable dose (MTD), dose-limiting toxicity (DLT), and dose range, for Phase I clinical trial design. It also provides pharmacokinetic evidence of drug interactions between cancer drugs and other relevant knowledge. DrugCombo currently integrates 8577 drug/target interactions and 8797 drug interactions from DrugBank, 3995 severe adverse drug events (ADEs), 95,535 common ADEs from drug labels, 1,816,030 ADEs from FAERS, and MTD and DLTs from 2592 Phase I trials.
Reference: https://doi.org/10.1158/1538-7445.AM2023-6573 , https://doi.org/10.1200/JCO.2023.41.16_suppl.1571
Contact: Lang Li